首页|支气管哮喘呼出气一氧化氮与支气管激发试验的相关性研究

支气管哮喘呼出气一氧化氮与支气管激发试验的相关性研究

扫码查看
目的:探讨分析呼出气一氧化氮(Fractional exhaled Nitric Oxide,FeNO)与乙酰甲胆碱(methacholine)支气管激发试验(bronchial provocation test,BPT)能否反应哮喘控制程度及二者的相关性分析,评估二者在支气管哮喘诊断及疗效评价方面的临床价值。方法:选取2012.1-2013.10新乡市中心医院呼吸内科门诊支气管哮喘非急性发作期患者42例参加本研究测试,并根据《全球哮喘防治创议》2009方案非急性发作期哮喘控制状态分级标准分为控制组16例,部分控制组14例,未控制组12例。设正常对照组18例。首先进行呼出气一氧化氮测试,然后进行肺通气功能测试,最后进行乙酰甲胆碱支气管激发试验。应用FEV1(第1秒钟用力呼气容积)下降20%时乙酰甲胆碱的药物激发浓度(PC20)评价气道反应性。应用FeNO评价气道炎症。观察测试中间出现的不良反应。结果:参加测试者共60人,测试中间有7例退出。最终有哮喘控制组15例,部分控制组13例,未控制组10例,正常对照组15例完成呼出气一氧化氮、肺通气功能测试和乙酰甲胆碱支气管激发试验。哮喘控制组,部分控制组,未控制组FeNO结果、BPT 对数转换PC20(lnPC20)与正常对照组均有显著差异,有统计学意义,P<0.05。哮喘控制组,部分控制组,未控制组用力肺活量结果与正常对照组无显著差异,无统计学意义,P>0.05。直线相关分析结果显示:控制组、部分控制组、未控制组FeNO和支气管激发试验药物激发浓度lnPC20均有直线相关性,为负相关。(分别为r=-0.971,P<0.05;r=-0.948,P<0.05; r=-0.969,P<0.05)结论:1.评估哮喘控制状态需综合评定,不能单纯用呼出气一氧化氮结果来评定。2.呼出气一氧化氮与支气管激发试验PC20呈负相关。呼出气一氧化氮反映的气道炎症与支气管激发试验反映的气道反应性呈正相关。3.在临床诊断及疗效评价方面,呼出气一氧化氮可部分取代支气管激发试验评价支气管哮喘患者的气道炎症及气道高反应性。
The correlation analysis of asthma fractional exhaled nitric oxide and bronchial provocation tests
Objective To compare the value of fractional exhaled nitric oxide(FeNO) and methacholine bronchial provocation test(BPT) the degree of asthma control status. To investigate the correlation analysis between them and evaluate the clinical value in diagnosis and treatment of asthma.Methods:We selected 42 cases non-acute episode asthma join in the testing from Clinic of Respiratory Medicine in 2012.1-2013.10 Xinxiang city centre Hospital. Diagnostic criteria are in line with "Global Initiative for Asthma" (GINA 2009) and "Asthma Prevention Guideline" revised by the Chinese Medical Association, 2008.There is 18 cases in Normal group. Before the test, the selected candidates are asked to sign an informed consent. First we performed fractional exhaled nitric oxide test, then pulmonary function tests, and finaly Methacholine bronchial provocation test. The Methacholine provocative concentration PC20 when application FEV1 decreased by 20% evaluate airway reactivity. Fractional exhaled nitric oxide test evaluate the airway inflammation. Adverse reactions were observed among the test.Results There were a total of 60 people participated in the test. There were seven cases to exit the test. There were 53 cases completed the fractional exhaled nitric oxide and pulmonary function tests ,so as to methacholine bronchial provocation test, which divided into 15 cases of asthma control group, 13 cases of partial control group, 10 cases of uncontrol group, normal group of 15 cases. The result were significantly different in fractional exhaled nitric oxide and bronchial provocation test lnPC20 between Asthma and the normal group, statisticaly significant, P <0.05. The FVC showed no significant difference between Asthma and the normal group. no statistical significance,P> 0.05. Linear correlation analysis results display: the control group fractional exhaled nitric oxide and bronchial provocation test lnPC20 has linear correlation, negative correlation. (r = -0.971, P <0.05).The partial control group fractional exhaled nitric oxide and bronchial provocation test lnPC20 has linear correlation, negative correlation. (r = -0.948,P <0.05) .The uncontrol group fractional exhaled nitric oxide and bronchial provocation test lnPC20 has linear correlation, negative correlation. (r = -0.969,P <0.05)Conclusion:1. Fractional exhaled nitric oxide can not assessed asthma control status isolate .It requires a comprehensive ways.2. Fractional exhaled nitric oxide and bronchial provocation test PC20 was negative correlation with fractional exhaled nitric oxide.3. In the part of clinical diagnosis and treatment evaluation, the Fractional exhaled nitric oxide is an important method of measuring airway inflammation. Bronchial provocation test can be partialy replaced by Fractional exhaled nitric oxide in the evaluation of asthma airway inflammation and airway hyper responsiveness.

Bronchial provocation testfractional exhaled nitric oxideasthmamethacholine

王志新、陈永凤、陈宏民

展开 >

新乡医学院附属中心医院 河南 新乡 453100

支气管激发试验 呼出气一氧化氮 支气管哮喘 乙酰甲胆碱

2014

中国保健营养(中旬刊)
全国卫生产业企业管理协会

中国保健营养(中旬刊)

ISSN:1004-7484
年,卷(期):2014.(7)
  • 2